Androgen Receptor IHC

This test measures the levels of the androgen receptor protein in tissue samples.

• Diagnose prostate cancer: The IHC AR test is one of the most important tests used to diagnose prostate cancer.
• Guide treatment decisions: For prostate cancer that is likely to respond to hormone therapy, the IHC AR test can help to guide treatment decisions.
• Monitor treatment response: The IHC AR test can be used to monitor the response to hormone therapy.
• In some cases, the IHC AR test may be used to identify individuals who are at high risk of developing prostate cancer, such as those with a family history of the disease.
• Diagnose breast cancer: The IHC AR test can be used to diagnose breast cancer. It can also be used to determine whether a breast cancer is likely to respond to hormone therapy.
• Diagnose endometrial cancer: The IHC AR test can be used to diagnose endometrial cancer. It can also be used to help determine the prognosis (outlook) for endometrial cancer.

Your doctor may recommend this test if you have:

• Symptoms or risk factors suggestive of androgen receptor-related disorders or conditions
• Been diagnosed with certain types of cancer, such as prostate cancer
• Undergone treatment for cancer that targets androgen receptors
• A family history of cancer or genetic risk factors for androgen receptor-related disorders

Abnormal results may indicate various conditions, such as prostate cancer, androgen insensitivity syndrome, or hormone therapy resistance. Consult your doctor, who will interpret the results, considering your medical history and additional tests if needed.

• Your doctor will collect a tissue sample, typically from a biopsy or surgical specimen.
• The sample will be sent to the laboratory for analysis.
• In the laboratory, specialised staining techniques are used to detect and quantify the androgen receptor protein.
• The results will be interpreted by a pathologist.

There are no specific preparations required before this test. However, it is important to speak to your healthcare provider about any specific requirements, such as fasting, medication, or other conditions.

• PSA (prostate-specific antigen) blood test: This test measures the levels of PSA in the blood and is commonly used to screen for and monitor prostate cancer.
• Genetic testing: This helps identify specific gene mutations associated with androgen receptor-related disorders or conditions.
• Imaging studies: MRI or CT scans provide additional information about the presence and extent of tumours.

• IHC Androgen Receptor with Interpretation
• Androgen Receptor Immunohistochemistry (IHC) with Interpretation

Prostate cancer is a type of cancer that develops in the prostate gland, which is part of the male reproductive system. It occurs when cells in the prostate gland start to grow uncontrollably, forming a tumour. Early detection and treatment are crucial for better outcomes.